NCT05262842 2022-09-21JS001+IMP4297 in Patients With Advanced CancerShanghai Junshi Bioscience Co., Ltd.Phase 1 Withdrawn
NCT02432612 2016-03-02A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced CancerGWPharmPhase 1 Withdrawn